Pfs Investments Inc. Eli Lilly & CO Transaction History

Pfs Investments Inc.

$6.12 Billion
Q2 2023

A detailed history of Pfs Investments Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Pfs Investments Inc. holds 16,049 shares of LLY stock, worth $12.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

16,049

Previous 3,026 430.37%

Holding current value

$12.5 Million

Previous $1.11 Million 575.67%

% of portfolio

0.12%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $4.57 Million - $6.11 Million	13,023 Added 430.37%	16,049 $7.53 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $172,089 - $202,110	554 Added 22.41%	3,026 $1.11 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $88,104 - $102,659	-274 Reduced 9.98%	2,472 $904,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $267,128 - $304,420	901 Added 48.83%	2,746 $888 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $78,044 - $91,635	280 Added 17.89%	1,845 $598,000
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $367,289 - $456,447	1,565 New	1,565 $448,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $3.47 Million - $4.18 Million	-25,436 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $610,131 - $755,168	5,125 Added 25.23%	25,436 $3.53 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $500,599 - $620,037	4,682 Added 29.96%	20,311 $2.67 Million
Q3 2019 Nov 05, 2019	BUY	$106.79 - $116.16 $502,446 - $546,532	4,705 Added 43.07%	15,629 $1.75 Million
Q2 2019 Jul 10, 2019	BUY	$110.79 - $129.32 $668,063 - $779,799	6,030 Added 123.21%	10,924 $1.23 Million
Q1 2019 Apr 05, 2019	BUY	$111.31 - $131.02 $544,751 - $641,211	4,894 New	4,894 $635,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pfs Investments Inc. with notifications on news.

Account

Pfs Investments Inc. Eli Lilly & CO Transaction History